Oncternal Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Oncternal Therapeutics

08/08/2024 22:22

* Oncternal Therapeutics Inc  ONCT.OQ  reported a quarterly
adjusted loss of $2.89​​ per share for the quarter ended in
June, higher than the same quarter last year, when the company
reported EPS of $-3.00.  The mean expectation of three analysts
for the quarter was for a loss of $3.10 per share. Wall Street
expected results to range from $-3.15 to $-3.06 per share.
    * Revenue rose 655.7% to $801.00 thousand from a year ago;
analysts expected $237.50 thousand. 
    * Oncternal Therapeutics Inc's reported EPS for the quarter
was a
loss of $2.89​.
    * The company reported a quarterly loss of $8.56 million.
    * Oncternal Therapeutics Inc shares had fallen by 24.5% this
quarter and lost 46.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 19.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Oncternal
Therapeutics Inc is $25.00 
This summary was machine generated from LSEG data August 8 at
09:22 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -3.10          -2.89          Beat
 Mar. 31 2024      -2.88          -2.83          Beat
 Dec. 31 2023      -3.07          -3.11          Missed
 Sep. 30 2023      -2.90          -3.40          Missed